Search This Blog

Thursday, February 27, 2020

Ra Pharmaceuticals EPS misses by $0.16

Ra Pharmaceuticals (NASDAQ:RARX): Q4 GAAP EPS of -$0.79 misses by $0.16.
Cash and cash equivalents of $264.99M.
Press Release
https://seekingalpha.com/news/3546411-ra-pharmaceuticals-eps-misses-0_16
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)